| ¿µ¹® | variant | ÇÑ±Û | º¯Çü, º¯ÀÌ |
|---|---|---|---|
| ¼³¸í | 1.¼Ò¼ÓÇÏ´Â ºÎ·ù¿Í ´Ù¸¥ ¼ºÁúÀ» °®´Â °ÍÀÇ ÃÑĪ, ¶Ç´Â ÀϺΠƯº°ÇÑ ¼ºÁú¸¸ Ʋ¸®´Â °Í¿¡ »ç¿ëµÇ´Â ´Ü¾î. 2. »ý¹°ÇÐ»ó µ¿Á¾ÀÇ »ý¹°¿¡¼ º¼ ¼ö ÀÖ´Â ÇüÁúÀÇ Â÷ÀÌ. |
||
| ¿µ¹® | surface tension | ÇÑ±Û | Ç¥¸éÀå·Â |
|---|---|---|---|
| ¼³¸í | ¾×üÀÇ ÀÚÀ¯Ç¥¸é¿¡¼ Ç¥¸éÀ» ÀÛ°ÔÇÏ·Á°í ÀÛ¿ëÇÏ´Â Àå·Â. ºñ´©¹æ¿ïÀ̳ª ¾×ü ¼ÓÀÇ ±âÆ÷-¹°¹æ¿ï µîÀÌ ±¸»óÀÌ µÇ´Â °ÍÀº ÀÌ ÈûÀÌ ¾×¸é¿¡ ÀÛ¿ëÇϱ⠶§¹®À̸ç, ¿ë±âÀÇ °¡ÀåÀÚ¸®¿¡ ¾×ü°¡ ³ÑÃÄ ¿Ã¶ó°£ ¸ð¾çÀÌ µÇ¾î ½ñ¾ÆÁöÁö ¾Ê´Â °Íµµ ¾×ü Ç¥¸é¿¡ Àå·ÂÀÌ ÀÛ¿ëÇϱ⠶§¹®ÀÌ´Ù. ¼ö¸é¿¡ ¶³¾î¶ß¸° ±â¸§¹æ¿ïÀÌ ±Ý¹æ ÆÛÁö´Â °ÍÀº ¹°ÀÇ Ç¥¸éÀå·ÂÀÌ ±â¸§ÀÇ Ç¥¸éÀå·Âº¸´Ù Å©°í, ±â¸§ÃþÀÌ ¹°ÀÇ Ç¥¸éÀå·Â¿¡ ÀÇÇØ Àâ¾Æ ´Ã¿©Áö±â ¶§¹®ÀÌ´Ù. |
||
| VSG | variant surface glycoprotein |
|---|---|
| L-variant | a defective bacterial variant that can multiply on hypertonic medium |
| VSA | variant-specific surface antigen |
| SGP | serine glycerophosphatide; sialoglycoprotein; Society of General Physiologists; soluble glycoprotein... |
| AMLSGA | acute myeloblastic leukemia surface glycoprotein antigen |
| VSG | Variant Surface Glycoprotein |
|---|---|
| VSG | Variant-specific Surface Glycoprotein |
| VSG | Variant Specific Glycoprotein |
| VSP | variant-specific surface protein |
| VSG | Variable surface glycoprotein |
| variant surface glycoproteins, trypanosoma | Glycoproteins attached to the surface coat of the trypanosome. Many of these glycoproteins show amino acid sequence diversity expressed as antigenic variations. This continuous development of antigenically distinct variants in the course of infection ensures that some trypanosomes always survive the development of immune response to propagate the infection. (12 Dec 1998) |
|---|
| variable surface glycoprotein | <protein> One of a battery of antigenicdeterminants expressed by a microorganism to elude immune detection. (09 Oct 1997) |
|---|---|
| invariant surface glycoprotein 100 | <chemical> A stage-specific invariant surface protein in trypanosoma brucei containing an internal, serine-rich, repetitive motif; amino acid sequence given in first source; genbank y14833 Synonym: isg-100 (05 Dec 1998) |
| angina pectoris, variant | A clinical syndrome characterised by development of chest pain at rest with concomitant transient st segment elevation in the electrocardiogram, but exercise capacity is well preserved. (12 Dec 1998) |
| variant | Something which differs in form from another thing, though really the same; as, a variant from a type in natural history; a variant of a story or a word. Origin: Cf. F. Variante. Source: Websters Dictionary (01 Mar 1998) |
| variant angina | A sudden vasoconstriction of a coronary artery depriving the myocardium of blood flow and oxygen. This may clinically manifest as chest pain referred to as variant angina or Printzmetal's angina. May be precipitated by emotional stress, medications, street drugs (cocaine) or on exposure to cold. Treatment includes nitroglycerin or beta-blocker medications. (27 Sep 1997) |
| variant angina pectoris | A form of angina pectoris, characterised by pain that is not precipitated by cardiac work, is of longer duration, is usually more severe, and is associated with unusual electrocardiographic manifestations including elevated ST segments in leads that are ordinarily depressed in typical angina, and usually without reciprocal ST changes; occurring at night in bed. Synonym: angina inversa, variant angina pectoris. (05 Mar 2000) |
| variant haemoglobin | A harmless mutant form of Hb. (05 Mar 2000) |
| a1-acid glycoprotein | <biology> Plasma protein of mammals and birds, 38% carbohydrate. In humans a single chain glycoprotein of 39 kD. Increased levels are associated with inflammation, pregnancy and various diseases. (18 Nov 1997) |
| acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase | <enzyme> Forms oligosaccharide core class 3 (glcnac beta 1-3galnac) in mucins and various glycoproteins Registry number: EC 2.4.1.147 Synonym: udp-glcnac-galnac-r beta 3-acetylglucosaminyltransferase, agggag-transferase (26 Jun 1999) |
| amyloidogenic glycoprotein | <protein> An integral membrane glycoprotein of the brain and related to the Drosophila vnd gene product. A precursor of _ amyloid, that accumulates in Alzheimer's disease and Down's syndrome. See: amyloid precursor protein. (18 Nov 1997) |
| b2-glycoprotein II | <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase. Registry number: EC 3.4.21.47 (12 Dec 1998) |
| beta-1,3-galactosyl-0-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase | <enzyme> Capable of adding a glcnac residue to g1cnacman(3)g1cnac; from mung bean seedlings Registry number: EC 2.4.1.146 Synonym: n-acetylglucosaminyltransferase II, gal3-(glcnac6)galnac-mucin (glcnac--gal)3-glcnactransferase (26 Jun 1999) |
| beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-acetylglucosaminyl transferase | <enzyme> With EC 2.4.1.148 this is called beta6-glcnac-transferase b Registry number: EC 2.4.1.102 Synonym: gal3-galnac-mucin-6-glcnac transferase, udp-glcnac-gal1-3galnac-r-(glcnac to galnac)-beta1-6glcnac transferase, core 2 glcnac transferase, core 2-n-acetylglucosaminyltransferase, core 2 beta6-gn-t (26 Jun 1999) |
| beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase | <enzyme> Induced in preneoplastic stage of liver carcinogenesis promoted by orotic acid in rats; adds "bisecting n-acetylglucosaminyl residue in beta 1,4 linkage to the beta-linked mannose of the core of asparagine-linked oligosaccharides Registry number: EC 2.4.1.144 Synonym: n-acetylglucosaminyltransferase III, udpgnac-glycopeptide beta4-n-acetylglucosaminyl transferase III, udpgnac-magtransferase III, udp-n-acetylglucosamine-beta-d-mannoside beta-1,4-n-acetylglucosaminyltransferase III (26 Jun 1999) |
| carbohydrate-deficient glycoprotein syndrome | <syndrome> An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors. (12 Dec 1998) |
Synonyms : SSP-4, VSG 117, VSG 118, VSG 221
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|